共 212 条
[1]
Angus DC(2001)Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 1303-1310
[2]
Linde-Zwirble WT(2002)Cytokine modulation in sepsis and septic shock Expert Opin Investig Drugs 11 1061-1075
[3]
Lidicker J(1996)Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The soluble TNF receptor sepsis study group N Engl J Med 334 1697-1702
[4]
Clermont G(2008)Sepsis mortality prediction based on predisposition, infection and response Intensive Care Med 34 496-504
[5]
Carcillo J(2003)Molecular characterization of the acute inflammatory response to infections with gram-negative versus gram-positive bacteria Infect Immun 71 5803-5813
[6]
Pinsky MR(2010)Toll-like receptors 2 and 4: initiators of non-septic inflammation in critical care medicine? Intensive Care Med 36 1826-1835
[7]
Zanotti S(1975)Formation of extracellular lipoteichoic acid by oral streptococci and lactobacilli Infect Immun 12 378-386
[8]
Kumar A(1998)Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Antimicrob Agents Chemother 42 3073-3078
[9]
Fisher CJ(2002): quantitative measurements and biological reactivities Am J Respir Crit Care Med 165 1445-1450
[10]
Agosti JM(2007)Differential role of interleukin-6 in lung inflammation induced by lipoteichoic acid and peptidoglycan from Shock 28 570-575